Tamboli Ajim 4
4 · Monte Rosa Therapeutics, Inc. · Filed Jan 4, 2023
Insider Transaction Report
Form 4
Tamboli Ajim
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-01-03+129,850→ 129,850 totalExercise: $7.78Exp: 2033-01-02→ Common Stock (129,850 underlying)
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on January 1, 2024, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.